[The use of p53 as a tool for human cancer therapy].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Молекулярная биология

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 18318112PMCID PMC2634859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53].

  2007cited by this paper
• Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

  2007cited by this paper
• Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro

  2006cited by this paper
• Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.

  2006cited by this paper
• Adenoviral gene therapy in head and neck cancer.

  2006cited by this paper
• Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin

  2006cited by this paper
• Growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus vector in glioblastoma cells.

  2006cited by this paper
• Dissecting p53-dependent apoptosis

  2006cited by this paper
• Adenovirus-Mediated p53 Treatment Enhances Photodynamic Antitumor Response

  2006cited by this paper
• Induction of efficient apoptosis and cell‐cycle arrest in tumor cells by adenovirus‐mediated p53 A4 mutant

  2006cited by this paper
• Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.

  2006cited by this paper
• TIGAR, a p53-inducible regulator of glycolysis and apoptosis.

  2006cited by this paper
• PCTAIRE3: a putative mediator of growth arrest and death induced by CTS-1, a dominant-positive p53-derived synthetic tumor suppressor, in human malignant glioma cells

  2006cited by this paper
• Complicating the complexity of p53.

  2005cited by this paper
• The NH2 Terminus of Influenza Virus Hemagglutinin-2 Subunit Peptides Enhances the Antitumor Potency of Polyarginine-mediated p53 Protein Transduction*

  2005cited by this paper
• Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells

  2005cited by this paper
• Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.

  2005cited by this paper
• Chemotherapy Compounds in Cervical Cancer Cells Primed by Reconstitution of p53 Function after Short Interfering RNA-Mediated Degradation of Human Papillomavirus 18 E6 mRNA: Opposite Effect of siRNA in Combination with Different Drugss⃞

  2005cited by this paper
• Clinical study of recombinant adenovirus-p53 (Adp53) combined with hyperthermia in advanced cancer (a report of 15 cases)

  2005cited by this paper
• The antioxidant function of the p53 tumor suppressor

  2005cited by this paper
• Reactivation of Mutant p53 and Induction of Apoptosis in Human Tumor Cells by Maleimide Analogs*

  2005cited by this paper
• Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitor

  2005cited by this paper
• The p53 pathway: positive and negative feedback loops

  2005cited by this paper
• Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.

  2005cited by this paper
• Ubiquitination‐resistant p53 protein transduction therapy facilitates anti‐cancer effect on the growth of human malignant glioma cells

  2005cited by this paper
• Targeting protein–protein interactions for cancer therapy

  2005cited by this paper
• Oncolytic Virotherapy as a Novel Strategy for Pancreatic Cancer

  2004cited by this paper
• Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

  2004cited by this paper
• Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells.

  2004cited by this paper
• Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA.

  2004cited by this paper
• Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53

  2004cited by this paper
• Gene therapy strategies to improve the effectiveness of cancer radiotherapy

  2004cited by this paper
• Post-translational modification of p53 in tumorigenesis

  2004cited by this paper
• Wild-type p53 gene transfer is not detrimental to normal cells in vivo: implications for tumor gene therapy

  2004cited by this paper
• Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD

  2004cited by this paper
• Inhibition of the p53-MDM2 interaction: targeting a protein-protein interface.

  2004cited by this paper
• Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors

  2004cited by this paper
• Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells.

  2004cited by this paper
• Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

  2004cited by this paper
• Nuclear delivery of p53 C-terminal peptides into cancer cells using scFv fragments of a monoclonal antibody that penetrates living cells.

  2003cited by this paper
• Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.

  2003cited by this paper
• Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field.

  2003cited by this paper
• Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide

  2003cited by this paper
• Parc: a cytoplasmic anchor for p53.

  2003cited by this paper
• Activation of p53 by the cytoprotective aminothiol WR1065: DNA-damage-independent pathway and redox-dependent modulation of p53 DNA-binding activity.

  2003cited by this paper
• Chemosensitization and Radiosensitization of Human Cancer by Antisense Anti‐MDM2 Oligonucleotides

  2003cited by this paper
• siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

  2003cited by this paper
• Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.

  2003cited by this paper
• Rescue of mutant p53 transcription function by ellipticine

  2003cited by this paper
• Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.

  2003cited by this paper
• Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation

  2003cited by this paper
• VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo

  2002cited by this paper
• Adenovirus-Mediated p14 ARF Gene Transfer Cooperates with Ad5CMV-p53 to Induce Apoptosis in Human Cancer Cells

  2002cited by this paper
• Self-Assembly of a Virus-Mimicking Nanostructure System for Efficient Tumor-Targeted Gene Delivery

  2002cited by this paper
• Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

  2002cited by this paper
• Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function

  2002cited by this paper
• Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil

  2002cited by this paper
• Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database.

  2002cited by this paper
• The RB and p53 pathways in cancer.

  2002cited by this paper
• p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma

  2002cited by this paper
• ONYX-015, an E1B gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines.

  2002cited by this paper
• Characterization of the p53-rescue drug CP-31398 in vitro and in living cells

  2002cited by this paper
• Interaction between p53 and p16 expressed by adenoviral vectors in human malignant glioma cell lines.

  2002cited by this paper
• Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus

  2002cited by this paper
• Construction of Chimeric Tumor Suppressor p53 Resistant to the Dominant-Negative Interaction with p53 Mutants

  2002cited by this paper
• The IARC TP53 database: New online mutation analysis and recommendations to users

  2002cited by this paper
• Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers

  2002cited by this paper
• Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.

  2002cited by this paper
• Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells.

  2002cited by this paper
• A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants

  2002cited by this paper
• Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment.

  2001cited by this paper
• Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin)

  2001cited by this paper
• Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.

  2001cited by this paper
• Mutant p53: the loaded gun.

  2001cited by this paper
• Gene therapy approaches for the management of non-small cell lung cancer.

  2001cited by this paper
• Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.

  2001cited by this paper
• Systemic p53 Gene Therapy of Cancer with Immunolipoplexes Targeted by Anti-Transferrin Receptor scFv

  2001cited by this paper
• Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.

  2001cited by this paper
• Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?

  2001cited by this paper
• Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53.

  2001cited by this paper
• Gene delivery using a receptor‐mediated gene transfer system targeted to hepatocellular carcinoma cells

  2001cited by this paper
• Non-viral vectors in cancer gene therapy: principles and progress

  2001cited by this paper
• Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay

  2001cited by this paper
• The Human Papillomavirus E6 protein and its contribution to malignant progression

  2001cited by this paper
• The role of natural killer cells in adenovirus-mediated p53 gene therapy.

  2001cited by this paper
• Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies.

  2001cited by this paper
• Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy

  2001cited by this paper
• Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

  2000cited by this paper
• Mechanism of rescue of common p53 cancer mutations by second‐site suppressor mutations

  2000cited by this paper
• Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

  2000cited by this paper
• p53 and human cancer: the first ten thousand mutations.

  2000cited by this paper
• Function of the p53 gene: choice between life and death.

  2000cited by this paper
• Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts.

  2000cited by this paper
• Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.

  2000cited by this paper
• Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.

  2000cited by this paper
• Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells

  2000cited by this paper
• In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha(nu)beta5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma.

  2000cited by this paper
• Efficiency of Adenovirus-Mediated Gene Transfer to Oropharyngeal Epithelial Cells Correlates with Cellular Differentiation and Human Coxsackie and Adenovirus Receptor Expression

  2000cited by this paper

• Diospyros malabarica fruit preparation mediates immunotherapeutic modulation and epigenetic regulation to evoke protection against non-small cell lung cancer (NSCLC).

  2023cites this paper
• Differential miRNA Expression in Human Macrophage-Like Cells Infected with Histoplasma capsulatum Yeasts Cultured in Planktonic and Biofilm Forms

  2021cites this paper
• Mathematical Modeling of a Positive Connection in the p53-microRNA Tumor Marker System

  2019cites this paper
• Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.

  2019cites this paper
• Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity

  2019cites this paper
• ПОЛИМОРФИЗМ ГЕНА ТР53 У ПАЦИЕНТОВ С РАКОМ ЖЕЛУДКА В ПОПУЛЯЦИОННОМ ПРОСПЕКТИВНОМ И КЛИНИЧЕСКОМ ИССЛЕДОВАНИЯХ

  2018cites this paper
• A well-controlled BioID design for endogenous bait proteins

  2018cites this paper
• A study on the expression pattern of key apoptotic regulators in Acute Myeloid Leukemia patients from the North-East Indian regions ” *

  2017cites this paper
• Important molecular genetic markers of colorectal cancer

  2016cites this paper
• N‐Benzylcinnamide induces apoptosis in HPV16 and HPV18 cervical cancer cells via suppression of E6 and E7 protein expression

  2015cites this paper
• Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides

  2013cites this paper
• Oncolytic adenoviruses in anticancer therapy: Current status and prospects

  2012cites this paper
• Assessing Cell and Organ Senescence Biomarkers

  2012cites this paper
• Valproic acid decreases the reparation capacity of irradiated MOLT-4 cells

  2012cites this paper
• The emerging role of viruses in the treatment of solid tumours.

  2011cites this paper
• Second Primary Tumor : P 53 and Ki-67 Expression in Patients with Oral Squamous Cell Carcinoma Corresponding

  2011cites this paper
• Targeted gene therapy for canine osteosarcoma : preliminary investigations

  2010cites this paper
• Investigating the Molecular Mechanism of Novel Quinuclidinone Derivatives in Lung Cancer Cells with Different p53 Status

  2010cites this paper
• Noninvasive assessment of regulable transferred-p53 gene expression and evaluation of therapeutic response with FDG–PET in tumor model

  2010cites this paper
• Constitutive and induced functions of the p53 gene

  2010cites this paper
• Czynniki biochemiczne i genetyczne w diagnostyce i prognozowaniu przebiegu chorób nowotworowych Biochemical and genetic factors in the diagnosis and prognosis of cancer

  2010cites this paper
• Versatile functions of p53 protein in multicellular organisms

  2007cites this paper
• Review Assessing Cell and Organ Senescence Biomarkers Telomere-dependent Senescence and Aging

  year unknowncites this paper